WASHINGTON (AP) — The same strategy that Martin Shkreli used to get away with a 5,000-percent price increase on an old drug is used by many other drugmakers to maintain sky-high prices on billions of ...
It’s not just drugmakers reshaping the pharmaceutical sector; distributors are rapidly transforming, too. While most investors and policymakers focus on rising prescription drug prices or ...
Orphan drug strategies to help 340B health systems achieve more Orphan drugs have been making headlines for decades — not only for bringing new treatment options to patients with rare conditions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results